Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.132
+0.002 (0.18%)
May 22, 2025, 12:20 PM - Market open
Vivani Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
37
Market Cap
67.06M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
VANI News
- 2 days ago - I Missed The Quantum Rally - I Won't Miss The Next One - Seeking Alpha
- 8 days ago - Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 15 days ago - Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop - GlobeNewsWire
- 5 weeks ago - Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - GlobeNewsWire
- 7 weeks ago - Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - Vivani Medical Announces $8.25M Private Placement Equity Financing - GlobeNewsWire
- 2 months ago - Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing - GlobeNewsWire
- 2 months ago - Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025 - Business Wire